Postdoctoral Training Fellow (Cancer Therapeutics)

Institute of Cancer Research - Division of Cancer Therapeutics

Team: Target Evaluation and Molecular Therapeutics
Length of Contract: 3 Years
Hours per week: 35 

The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. We provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today, The Institute of Cancer Research (ICR) leads the world at isolating cancer-related genes and discovering new targeted drugs for personalised cancer treatment. Under the leadership of our Chief Executive, Professor Paul Workman FRS, the ICR is ranked as the UK’s leading academic research centre. Together with our partner The Royal Marsden, we are rated in the top four cancer centres globally. The ICR is committed to attracting, developing and retaining the best minds in the world to join us in our mission – to make the discoveries that defeat cancer. 

The Cancer Research UK Cancer Therapeutics Unit, part of the Division of Cancer Therapeutics, is a multidisciplinary 'bench to bedside' centre, comprising around 160 staff dedicated to the discovery and development of novel therapeutics for the treatment of cancer. The CRUK Cancer Therapeutics Unit’s exciting goal is to discover high quality drug candidates for validated biological targets and to progress these candidates to clinical trial. All the scientific disciplines are in place to make this possible.  Our biologists work alongside world-class chemists and drug metabolism specialists focusing on new molecular targets emerging from human genome and ground-breaking cell biology research.  This is an exciting and fat moving area of cancer research, and offers the opportunity to work within a multi-disciplinary environment using state-of-the-art techniques and equipment. 

We have an opportunity for a talented and motivated postdoctoral training fellow to join our Target Evaluation and Molecular Therapeutics (TEMT) team, within the Division of Cancer Therapeutics.  The TEMT team has a dual role in developing assays and strategies to support drug discovery and investigating the underlying biology of cancer targets and the response to targeted therapeutics.  The successful candidate will work on an on-going drug discovery project, contributing to an understanding of target biology, developing and testing therapeutic hypotheses, and discovering biomarkers of response to target inhibition. 

Applicants should have a PhD degree in cell biology, cancer biology, genetics, biochemistry or similar.  Experience in mammalian cell biology techniques, including cell culture, is essential.  Applicants should be committed to working within a multi-disciplinary environment to discover and progress novel cancer therapeutics.  Excellent organisational and communication skills are also required. 

The position is offered on a fixed term 3-year contract.  Starting salary is in the range of £29,960 to £34,247 per annum inclusive based on experience.  

Informal enquiries can be made via email to  Please note, this address is for enquiries only.  

For further information and to apply, please click on the 'Apply' button below. 

We consider all applications on merit and have a strong commitment to enhancing the diversity of our staff.

Share this job
  Share by Email   Print this job   More sharing options
We value your feedback on the quality of our adverts. If you have a comment to make about the overall quality of this advert, or its categorisation then please send us your feedback
Advert information

Type / Role: